Connect your AI

Staar Surgical STAA Investment Purchases

Investment Purchases at other companies

Johnson & JohnsonJNJ

$144M-42.6%

IAR

Integra LifeSciencesIART

$0-100%

Bausch + LombBLCO

$38M+217%

Other financials

Income statement

Revenue$93.5M+120%

Gross profit$68.9M+146%

Operating income$8.0M+114%

Net income$5.2M+110%

EPS (diluted)$0.10+109%

Balance sheet

Cash & equivalents$131.9M-23.8%

Total debt$37.3M+1.7%

Total equity$352.4M+0.7%

Total assets$451.1M-1.4%

Cash flow

Operating cash flow-$21.7M-278%

CapEx$443.0K-69.8%

Free cash flow-$22.1M-207%

Valuation

Market cap$1.44B+77.9%

Enterprise value$1.35B+100.0%

P/S5×+2.1×

Profitability

Gross margin76.9%+2.9pp

Operating margin-9.1%-3.5pp

Net margin-7.2%-3.0pp

FCF margin-19.6%+55.9pp

Returns & leverage

Return on equity-6%-2.4pp

Debt / equity0.1×0.0×

Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Staar Surgical's investment purchases?: Staar Surgical (STAA) reported investment purchases of $4.52M in Q1 2026.
How has Staar Surgical's investment purchases changed year-over-year?: Staar Surgical's investment purchases decreased by 69.2% year-over-year, from $14.69M to $4.52M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.